Group 1 - The core message of the news is that Tongrentang Group is taking significant actions to address the issues related to the unauthorized use of its brand and products, particularly in response to the controversy surrounding a product claiming to contain Antarctic krill oil [1][7][9] Group 2 - Tongrentang Group has initiated a comprehensive investigation and accountability measures, including the dismissal of the general manager of Sichuan Health Company and the suspension of other responsible personnel [1] - The company is actively cooperating with regulatory authorities in a joint investigation and has taken steps to recall the problematic products while monitoring their distribution channels [2] - A product information query system has been launched to help consumers identify genuine Tongrentang products, emphasizing the importance of the "Double Dragon Mark" for authenticity [3] - A special action for strict brand management has been initiated, resulting in the inspection of over 520 units and the filing of nearly 600 complaints against infringing products and stores [4] Group 3 - The Shanghai Consumer Protection Committee has identified serious discrepancies in the marketing of a product claiming to contain 43% phospholipids, which was found to contain none, leading to a formal investigation [7][8] - The company has acknowledged unauthorized use of its brand by Sichuan Health Company and has initiated legal proceedings against the involved parties [8] - Regulatory bodies are planning to implement stricter oversight on commissioned production practices to ensure product quality and consumer protection [9]
同仁堂:责令李声义辞职,其他相关管理人员全部停职